Skip to main content
Premium Trial:

Request an Annual Quote

Edico Genome, Amazon Web Services Partner on Cloud Bioinformatics

NEW YORK (GenomeWeb) – Edico Genome said today that it is partnering with Amazon Web Services to make Edico's Dragen bioinformatics platform available on new Amazon cloud-based instances.

"With AWS' newest [Field Programmable Gate Array]-based instances, Dragen will be able to analyze whole genomes in almost real time," Edico CEO Pieter van Rooyen said in a statement.

The Dragen platform offers hardware-accelerated implementation of genomic analysis algorithms, reducing analysis time. Specifically, Edico will be deploying it on the Amazon Elastic Compute Cloud (EC2) F1 instances.

It's yet another computing resource that Edico has integrated Dragen into. The firm has a deal with Intel to integrate the Dragen platform with Intel processors, and in May Edico announced a partnership with IBM to make Dragen available on one of IBM's high-performance computing servers.

The firm said that adding a cloud configuration provides customers the flexibility to scale up analysis when on-site resources are in high demand. "Pipelines are identical whether executed in the cloud or on-site," the firm said in a statement, adding that both systems can be managed using the Dragen web portal.

Pricing for the Dragen cloud solution has not yet been determined but will be announced by the end of 2016, Edico said.

"We look forward to offering a secure, highly scalable, and cost-efficient platform for genomic analysis to Edico customers, hospitals, academic institutions, drug developers, sequencing centers, and others advancing genomic-based work," van Rooyen said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.